• Find us on Facebook
  • Follow BMJ OnExamination on Twitter

Latest News

Like this article?

Click vote now

0

Possible bacterial drivers of IBD identified

from MNTcrohn - 02 Sep 14

Yale University researchers have identified a handful of bacterial culprits that may drive inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis, using patients' own...



0

Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis

from NEJM - 02 Sep 14

New England Journal of Medicine, Volume 0, Issue 0, Ahead of Print.



0

Immunotherapy for Tuberculous Pericarditis

from NEJM - 02 Sep 14

New England Journal of Medicine, Volume 0, Issue 0, Ahead of Print.



0

Septic acute kidney injury: molecular mechanisms and the importance of stratification and targeting therapy

from Critical Care Forum - 02 Sep 14

The most common cause of acute kidney injury (AKI) in hospitalized patients is sepsis. However, the molecular pathways and mechanisms that mediate septic AKI are not well defined. Experiments performed over the past 20 years suggest that there are profound differences in the pathogenesis between septic and ischemic AKI. Septic AKI often occurs independently of hypoperfusion, and is mediated by a concomitant pro- and anti-inflammatory state that is activated in response to various pathogen-associ



0

Yan Guo: shaping China's public health policy.

from Lancet - 02 Sep 14

Yan Guo: shaping China's public health policy. Lancet. 2014 Aug 30;384(9945):737 Authors: Holmes D PMID: 25176537 [PubMed - in process]



0

A call for abstracts from China.

from Lancet - 02 Sep 14

A call for abstracts from China. Lancet. 2014 Aug 30;384(9945):732 Authors: Cao X, Wang HH, Summerskill W, Lo S, Horton R PMID: 25176536 [PubMed - in process]



0

Can China age healthily?

from Lancet - 02 Sep 14

Can China age healthily? Lancet. 2014 Aug 30;384(9945):723-4 Authors: Zhao Y, Smith JP, Strauss J PMID: 25176535 [PubMed - in process]



0

Globalisation and environmental health in China.

from Lancet - 02 Sep 14

Globalisation and environmental health in China. Lancet. 2014 Aug 30;384(9945):721-3 Authors: Kan H PMID: 25176534 [PubMed - in process]



0

China's global health strategy.

from Lancet - 02 Sep 14

China's global health strategy. Lancet. 2014 Aug 30;384(9945):719-21 Authors: Minghui R, Guoping L PMID: 25176533 [PubMed - in process]



0

China Medical Board: a century of Rockefeller health philanthropy.

from Lancet - 02 Sep 14

China Medical Board: a century of Rockefeller health philanthropy. Lancet. 2014 Aug 30;384(9945):717-9 Authors: Chen LC PMID: 25176532 [PubMed - in process]



0

Obesity: a growing threat to health in China.

from Lancet - 02 Sep 14

Obesity: a growing threat to health in China. Lancet. 2014 Aug 30;384(9945):716 Authors: The Lancet PMID: 25176531 [PubMed - in process]



0

High quality care for all in the UK.

from Lancet - 02 Sep 14

High quality care for all in the UK. Lancet. 2014 Aug 30;384(9945):716 Authors: The Lancet PMID: 25176530 [PubMed - in process]



0

Taking China's health professional education into the future.

from Lancet - 02 Sep 14

Taking China's health professional education into the future. Lancet. 2014 Aug 30;384(9945):715 Authors: The Lancet PMID: 25176529 [PubMed - in process]



0

Effective treatment for depression in patients with cancer.

from Lancet - 02 Sep 14

Effective treatment for depression in patients with cancer. Lancet. 2014 Aug 28; Authors: Rodin G PMID: 25175951 [PubMed - as supplied by publisher]



0

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.

from Lancet - 02 Sep 14

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014 Aug 27; Authors: Sharpe M, Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G, for the SMaRT (Symptom Management Research Trials) Oncology-2 Team Abstract BACKGROUND: Medical conditions are often complicated by major depression, with conseque



0

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre,

from Lancet - 02 Sep 14

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study. Lancet Oncol. 2014 Aug 27; Authors: Seto T, Kato T, Nishio M, Goto K, Atagi S, Hosomi Y, Yamamoto N, Hida T, Maemondo M, Nakagawa K, Nagase S, Okamoto I, Yamanaka T, Tajima K, Harada R, Fukuoka M, Yamamoto N Abstract BACKGROUND: Wit



0

What new therapeutic targets exist for EGFR-mutant NSCLC?

from Lancet - 02 Sep 14

What new therapeutic targets exist for EGFR-mutant NSCLC? Lancet Oncol. 2014 Aug 27; Authors: Rosell R PMID: 25175098 [PubMed - as supplied by publisher]



0

Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.

from Lancet - 02 Sep 14

Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol. 2014 Aug 27; Authors: Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G, Sharpe M, for the SMaRT (Symptom Management Research Trials) Oncology-3 Team Abstract BACKGROUND: The management of depression in patients with poo



0

Research in brief.

from Lancet - 02 Sep 14

Research in brief. Lancet Diabetes Endocrinol. 2014 Aug 27; Authors: Kang S PMID: 25175009 [PubMed - as supplied by publisher]



0

The economics, financing and implementation of HIV treatment as prevention: What will it take to get there?

from Lancet - 02 Sep 14

The economics, financing and implementation of HIV treatment as prevention: What will it take to get there? Afr J AIDS Res. 2014 Jun;13(2):109-19 Authors: Wilson D, Taaffe J, Fraser-Hurt N, Gorgens M Abstract The 2013 Lancet Commission Report, Global Health 2035, rightly pointed out that we are at a unique place in history where a "grand convergence" of health initiatives to reduce both infectious diseases, and child and maternal mortality - di



0

Dromedary MERS-CoV replicates in human respiratory tissues.

from Lancet - 02 Sep 14

Dromedary MERS-CoV replicates in human respiratory tissues. Lancet Respir Med. 2014 Aug 28; Authors: Reperant LA, Osterhaus AD PMID: 25174550 [PubMed - as supplied by publisher]



0

Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study.

from Lancet - 02 Sep 14

Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014 Aug 28; Authors: Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, Ali MA, Tao KP, Ng HY, Chan MC, Guan Y, Nicholls JM, Peiris JS Abstract BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection causing severe viral pneumon



0

Generation Bias in Meta-Analysis of Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent.

from Am J Cardiol - 02 Sep 14

Generation Bias in Meta-Analysis of Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent. Am J Cardiol. 2014 Aug 4; Authors: Salman S PMID: 25175158 [PubMed - as supplied by publisher]



0

The Heart and Vascular Tree: Reflections on Imagery and the Practice of Cardiology.

from Am J Cardiol - 02 Sep 14

The Heart and Vascular Tree: Reflections on Imagery and the Practice of Cardiology. Am J Cardiol. 2014 Jul 30; Authors: Battle RW PMID: 25175157 [PubMed - as supplied by publisher]



0

Frequency and Significance of Myocardial Bridging and Recurrent Segment of the Left Anterior Descending Coronary Artery in Patients With Takotsubo Cardiomyopathy.

from Am J Cardiol - 02 Sep 14

Frequency and Significance of Myocardial Bridging and Recurrent Segment of the Left Anterior Descending Coronary Artery in Patients With Takotsubo Cardiomyopathy. Am J Cardiol. 2014 Jul 30; Authors: Stiermaier T, Desch S, Blazek S, Schuler G, Thiele H, Eitel I Abstract Despite intensive research efforts, the causative mechanisms of takotsubo cardiomyopathy (TC) are still unknown. Recently, morphologic characteristics of the left anterior descen


 

8744 items Page 135 of 350 << 130 131 132 133 134 135 136 137 138 139 140 >>

    Search

    Categories

    Keyword cloud

    back blood body brain breast cardiac change chronic Coupons diabetes dog Ebola England genetic great kidney lung NHS pain protein reviews surgical UK volume weight

    Top news voters

    tasmina.hakim120 votes
    ashrydr2 votes
    khaja3402 votes

    © 2014 BMJ Publishing Group Ltd . All rights reserved.